These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 29374616

  • 1. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.
    Cochrane Database Syst Rev; 2018 Jun 05; 6(6):CD006332. PubMed ID: 29869799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA, Sheridan EA.
    Ann Pharmacother; 2018 Apr 05; 52(4):370-379. PubMed ID: 29092627
    [Abstract] [Full Text] [Related]

  • 6. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM, Rhee D.
    Pharmacotherapy; 2016 Mar 05; 36(3):287-99. PubMed ID: 26945548
    [Abstract] [Full Text] [Related]

  • 7. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH.
    Aliment Pharmacol Ther; 2020 Jul 05; 52(1):37-53. PubMed ID: 32462777
    [Abstract] [Full Text] [Related]

  • 8. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K, Halawi H, Camilleri M.
    Neurogastroenterol Motil; 2018 May 05; 30(5):e13250. PubMed ID: 29119706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.
    Luthra P, Burr NE, Brenner DM, Ford AC.
    Gut; 2019 Mar 05; 68(3):434-444. PubMed ID: 29730600
    [Abstract] [Full Text] [Related]

  • 13. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
    Nishie K, Yamamoto S, Yamaga T, Horigome N, Hanaoka M.
    J Gastroenterol Hepatol; 2019 May 05; 34(5):818-829. PubMed ID: 30597600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM, Bilsky EJ.
    J Pharm Pract; 2018 Dec 05; 31(6):658-669. PubMed ID: 28946783
    [Abstract] [Full Text] [Related]

  • 17. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K, Sivaramakrishnan G.
    J Pain Symptom Manage; 2018 Feb 05; 55(2):468-479.e1. PubMed ID: 28919541
    [Abstract] [Full Text] [Related]

  • 18. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL.
    Drugs; 2013 Aug 05; 73(12):1297-306. PubMed ID: 23881667
    [Abstract] [Full Text] [Related]

  • 19. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW.
    Am J Health Syst Pharm; 2014 Sep 01; 71(17):1450-5. PubMed ID: 25147168
    [Abstract] [Full Text] [Related]

  • 20. Emerging therapies for opioid-induced constipation: what can we expect?
    Roostaei G, Khoshnam Rad N, Fakhri B MS, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2024 Sep 01; 25(13):1729-1738. PubMed ID: 39308446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.